Clin2
NCT06597188Possibly a fitEnrolling by invitation

TAVR vs. Surgery for severe bicuspid aortic valve stenosis

Aortic StenosisBicuspid Aortic Valve (BAV)

Part of Genetic & congenital, Heart & circulation clinical trials.

This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
452 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 75 years old or younger.
  • You have severe narrowing of your aortic valve due to a bicuspid valve (two leaflets instead of three).
  • You have symptoms like shortness of breath or chest pain (NYHA class II or higher).
  • Your surgical risk is low to intermediate as determined by your heart team.
  • You are willing to sign a consent form and follow the study requirements.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04722796Recruiting
TAVR for bicuspid aortic valve with a specific device

This study tests a “solution” approach using a self-expanding valve during TAVR (a less invasive way to replace a narrowed aortic valve). It aims to improve how well the valve fits and works in people with a specific heart valve shape (bicuspid aortic stenosis).

Bengbu, Anhui
NCT06924151Recruiting
Surgery for Aortic Valve in Low Risk Patients

This trial tests if surgery to replace your aortic valve is safe and effective for people with severe aortic stenosis who are at low risk for complications. It compares surgery to another procedure to see which works best.

Nagoya, Aichi-ken
NCT04414878Recruiting
Transcatheter aortic valve replacement for older, high-risk patients

This trial tests a new heart valve replacement done through a catheter (not open-heart surgery) in older adults with severe aortic valve narrowing. It’s mainly for people who are high-risk or not good candidates for standard surgery, to see if the new valve improves outcomes.

Beijing, Beijing Municipality
NCT06830499Recruiting
Sapien 3 valve for younger Chinese patients with severe aortic stenosis

This trial tests a newer artificial heart valve (Sapien 3) placed through a small tube in the leg, for younger people (50–70) with severe aortic stenosis. It aims to see if this less invasive option works well in this age group.

Xi'an, Shaanxi
NCT07413965Recruiting
Transcatheter vs surgical valve replacement for severe bicuspid aortic stenosis

This trial compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve. If you're 50 or older and need a new valve, this study can help figure out which approach works best.

Los Angeles, California
NCT06817148Recruiting
TAVR vs surgery for bicuspid aortic valve disease

This study compares two treatments for severe aortic stenosis in people with a bicuspid aortic valve: transcatheter aortic valve replacement (TAVR, a less invasive procedure) and surgical aortic valve replacement (SAVR, open-heart surgery). The goal is to see which approach works better for this specific condition.

Los Angeles, California

Hear when a new Aortic Stenosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.